Endocrine care of transpeople part II. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transwomen
- 25 March 2015
- journal article
- review article
- Published by Wiley in Clinical Endocrinology
- Vol. 83 (5) , 607-615
Abstract
The treatment of transwomen relies on the combined administration of anti-androgens or GnRH analogues to suppress androgen production and thereby reduce male phenotypic characteristics together with oestrogens to develop female characteristics. In transwomen, synthetic oestrogens such as ethinyl oestradiol, as well as conjugated equine oestrogens (CEE), should be avoided to minimize thromboembolic risks especially in older transwomen and in those with risk factors. Currently, available short- and long-term safety studies suggest that cross-sex hormonal therapy (CHT) can be considered safe in transwomen improving the well-being and quality of life of these individuals. Long-term monitoring should aim to decrease cardiovascular risks and should include prostate and breast cancer screenings.Keywords
This publication has 69 references indexed in Scilit:
- Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual PersonsThe Journal of Sexual Medicine, 2012
- Sperm Freezing in Transsexual WomenArchives of Sexual Behavior, 2012
- Children and Adolescents With Gender Identity Disorder Referred to a Pediatric Medical CenterPediatrics, 2012
- Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population‐based cohort studyBritish Journal of Clinical Pharmacology, 2011
- Continuing Medical Education: Sexual Functioning in Transsexuals Following Hormone Therapy and Genital Surgery: A Review (CME)The Journal of Sexual Medicine, 2009
- Autonomous prolactin secretion in two male-to-female transgender patients using conventional oestrogen dosages2009
- Androgen Receptor Repeat Length Polymorphism Associated with Male-to-Female TranssexualismBiological Psychiatry, 2009
- Spironolactone use and the risk of upper gastrointestinal bleeding: a population‐based case–control studyBritish Journal of Clinical Pharmacology, 2008
- Hypoactive sexual desire in transsexual women: prevalence and association with testosterone levelsEuropean Journal of Endocrinology, 2008
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002